十二生肖(十二属种)动物与人类进化论——人类起源的探索(三)

地球上十二属种动物与人类的关系存在决定意识,人们的社会存在决定人们的社会(思想)意识。人类产生“十二兽”观念并制订,实行十二兽历法,正是人类自身起源于“十二兽”的先祖这一客观事实在人们头脑中的反映。十二兽:我国又称十二禽,十二属,十二物,十二生肖等。所谓十二兽,我国汉族是指鼠,牛,虎,兔,龙,蛇,马,羊,猴,鸡,狗,猪。让我们从十二兽历法的产生和起源来探讨地球上十二属种动物(十二兽)的先祖与人类进化的关系。世界上四大文明古国———中国、印度、埃及和巴比伦各有其“十二兽历法”,内容上大同小异。中国汉族:鼠,牛,虎,兔,龙,蛇,…     

我想邂逅一只獾

<正>当窗外猫头鹰的"咕咕"声和外公的呼噜声配成一首滑稽的奏鸣曲,我知道,夜已经很深了。穿好衣服,提上鞋子,我蹑手蹑脚地溜出家门。今晚,对,趁着夜深人静,我要独自走入森林,找到外公提到过的那棵老橡树。哪怕田鼠啃咬我的脚趾,虫虫钻进我的衣领,我都会在树下屏住呼吸,耐心守候,因为……     

烟草趣话

笔者不会抽烟,不喜欢烟,记得小时候看大人吸烟,那是一小烟袋,铜制的,有个咀子放烟丝,另一头用嘴吸,烟袋里装有水,当用火柴点燃烟丝时,嘴就随时缓缓吸烟,几下子就吞云吐雾了。由于好奇,大人走后,我就仿效试试,由于吸气太大,一下子把烟袋中的水都吸到口里了,满嘴烟味极不好受,以后再不玩这东西了。后来时兴纸烟,当闻到烟气时头就不舒服,从此与烟绝了缘至今。     

植物大熊猫——野生红豆杉

野生红豆杉,冰川世纪遗留下来的古老树种,以它顽强的生命力屹立在地球上已几百万年。在人类出现在这个星球以前,它就以红彤彤的红豆果,扮靓了地球的山间和密林。它树姿优美,枝繁叶茂,苍劲挺拔,一派生机盎然,令人敬畏。它果实鲜红,艳丽无比,圆如珍珠,寄托相思之情,令人爱怜。它全身是宝,强身健体,防癌抗癌,历史悠久,令人感动。     

广西大戟科新种和新分布

<正> 灌木,通常高3米,枝条细,粗3—5毫米,树皮近灰色,具细条纹,小枝具翅,无毛。叶薄纸质,椭圆形至卵状长圆形,无毛;中脉细,两面凸起,侧脉纤细,5—7对,两面稍凸起,未达叶缘而网结,叶柄长不及2毫米,无毛;托叶挟三角形,长3—4毫米,基部扩大,近耳形,顶端急尖。花腋生,单朵或稀2朵簇生,萼片和花盘互生,无花辦。雄花:花梗丝状,长3—3.5厘米,基部被微柔毛;萼片4枚,覆瓦状排列,披针形,长4.5毫米,     

中国栅蛛属2新种记述(蜘蛛目:栅蛛科)

本文记了分别采自云南高黎贡山的栅蛛科栅蛛属Hahnia 2新种:垭口栅蛛,新种S.yakouensis sp.nov.和肾形栅蛛,新种S.reniformis sp.nov..垭口栅蛛后眼列前曲,交媾腔大,扁圆形,交媾孔1个,位于交媾腔下缘,交媾管粗,呈"人"字形下行分成2支再向两侧扭曲.纳精囊有一肓管斜向上伸出,鉴于上述特征而与Hahnia mridulae Tikader,1970不同.肾形栅蛛交媾孔2个,位于生殖厣腹面中央,纳精囊1对,大,肾形,插入器始于生殖球左下方,鉴于上述特征而与Hahnia xinjiangensis Wang et Liang,1989不同. Abstract： The present paper deals with two new species of the genus Hahnia collected from the Gaoligong Mountains Region of Yunnan Province, China: Hahnia yakouensis sp. nov., Hahnia reniformis sp. nov..     

青海蚕豆种质资源形态多样性分析

对153份青海蚕豆种质资源的形态多样性进行鉴定, 结果表明, 青海蚕豆种质资源具有丰富的形态多样性,平均多样性指数为0.8033,其中青海地方蚕豆品种多样性最丰富,平均多样性指数为0.8288.通过多变量的主成分分析,前6个主成分代表了蚕豆形态多样性的87.89%.基于形态性状,把153份蚕豆种质聚类并划分为3大组群.第Ⅰ组群,初花天数较长,植株中等,子粒中等,单株荚数和粒数多,单株产量较高;第Ⅱ组群,初花天数较短,株高较矮,子粒小,单株荚数和粒数较多,单株产量低;第Ⅲ组群,初花天数较短,株体较高,单株荚数和粒数少,但子粒较大,单株产量较高.     

中国琼楠属二新种

<正> 短叶琼楠 新种 图10 Beilschmiedia brevifolia Y. T. Wei, sp. nov. 乔木,高约8米,小枝略粗壮,无毛;树皮平滑或微裂;顶芽卵圆形,无毛,直径约5毫米,先端尖。叶薄革质,对生,常聚生于枝顶,椭圆形至狭椭圆状披针形,2.5—4(6)厘米,宽1.5—2.5(3)厘米,先端钝,基部近圆形,稀近楔形,两面无毛,干时腹面深灰色,背面黑褐色,中脉在叶面微下陷,在下面凸起;侧脉每边约7条,与网脉在两面凸起;叶柄短,长2—5毫米,无毛。花未见。果序顶生或腋生。果近球形,直经约1.5厘米,干后黑色,果     

象鼩吉森遇上偷窥狂

在非洲的坦桑尼亚北部,有一片茂密的森林,名叫丹堵鲁。为了追踪一种名叫岩象鼩的小动物,生物学家格蕾丝已经在这片森林里待了几个星期。此刻的她,双膝跪地、鼻尖儿蹭着泥,正聚精会神地调试着微型摄影机。哈,调试完毕,我简直是天才!格蕾丝咧开嘴巴,得意地咯咯笑着,这下我一定能……哎呦,什么什么东西钻进了我的鼻子,痒、痒,啊——阿嚏!     

广西容县84例狂犬病流行病学分析及预防对策

目的 通过对容县2000～2007年84例狂犬病流行病学特点进行分析,探讨流行回升的因素,分析目前防治过程中存在的问题,提出狂犬病的预防对策和措施.方法 收集2000～2007年容县狂犬病疫情报告资料及对狂犬病病例的个案调查资料进行分析.结果 近年来,容县狂犬病疫情明显上升,成为有史以来流行高峰,最高年发病率3.04/10万.发病以农民,学生为主,男性多于女性,全年均有病例发生,无明显季节性,狂犬病暴露动物以犬伤为主,暴露部位以头颈部为最危险,潜伏期最短.结论 为有效预防狂犬病流行,应进一步建立完善犬类的管理的法律、法规,使预防狂犬病进入法制轨道,以有效控制狂犬病流行.伤后未能及时正确处理,暴露后免疫率低,是狂犬病发生的重要原因.加强宣传,提高狂犬病的防控知识,政府部门齐抓共管,采取综合性防控措施,才能有效控制狂犬病的流行.     

鳜对葡萄糖和糊精利用差异比较研究

研究通过比较鳜(Siniperca chuatsi)对不同碳水化合物的利用差异, 探究肉食性鱼类对碳水化合物利用的分子机制。按照1670 mg/kg剂量对鳜灌喂葡萄糖和糊精后, 分别在0、1h、2h、3h、4h、8h、12h和24h收集水样、血浆、肝脏和肌肉, 检测尿糖、血糖、血甘油三酯、血胰岛素、肝糖原、肌糖原含量及糖代谢相关基因表达水平等指标。结果显示: (1) 灌喂后1—12h内, 两组鳜相比, 葡萄糖组尿糖显著高于糊精组, 血糖及胰岛素含量在两组间无显著差异; (2) 两组鳜甘油三酯含量在2h时达到最大值, 糊精组甘油三酯含量在4h时显著高于葡萄糖组, 糊精组肝糖原含量在1h时显著高于葡萄糖组, 且糊精组肌糖原含量在24h内均显著高于葡萄糖组; (3) 灌喂后1h, 灌喂糊精组葡萄糖激酶(Glucokinase, GK)、脂肪酸合成酶(Fatty Acid Synthetase, FAS)、乙酰辅酶A羧化酶Ⅰ型(Acetyl-CoA Carboxylase Type Ⅰ, ACC1)、柠檬酸合成酶(Citroyl Synthetase, CS)基因表达水平显著高于葡萄糖组, 而在灌喂后8h, 糊精组糖原合酶(Glycogen Synthase, GS)和CS基因表达水平却显著低于葡萄糖组。结果表明, 肉食性鱼类鳜摄入糖后可以促进糖原和脂肪的合成, 转化为糖原和甘油三酯, 从而减少未利用糖的排出, 且鳜对葡萄糖的利用效率低于糊精。     

Mice lacking Ca(v)2.3 (alpha1E) calcium channel exhibit hyperglycemia.

To investigate the functional role of Ca(v)2.3 channel in glucose homeostasis, we performed in vivo glucose tolerance and insulin tolerance tests together with stress-induced glucose release tests using mice deficient in Ca(v)2.3 channel (Ca(v)2.3-/-). The Ca(v)2.3-/- mice were significantly heavier than wild-type mice. In glucose tolerance and insulin tolerance tests, Ca(v)2.3-/- mice showed a significantly higher blood glucose level compared to wild-type mice. However, stress-induced blood glucose changes in Ca(v)2.3-/- mice were similar to those in wild-type mice. These results suggest that Ca(v)2.3 channel plays a role in glucose homeostasis by reducing insulin sensitivity and that Ca(v)2.3-/- mice exhibit symptoms resembling non-insulin-dependent diabetes mellitus.     

Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus

High blood glucose levels of KK-A(y) mice with type 2 diabetes mellitus were normalized by daily intraperitoneal (ip) administration of a zinc(II) complex, bis(maltolato)zinc(II) (Zn(Mal)(2)) with a Zn(O(4)) coordination mode, following the finding of strong in vitro insulinomimetic activity in isolated rat adipocytes treated with epinephrine in terms of the inhibition of free fatty acid release. The blood glucose level was maintained in the normal range during administration of the Zn(Mal)(2) complex for 14 days and improvements in the glucose tolerance were confirmed by an oral glucose tolerance test.     

胶原蛋白多肽-铬（Ⅲ）螯合物对糖尿病小鼠免疫力的影响

目的研究胶原蛋白多肽-铬（Ⅲ）（CPCC）螯合物对由四氧嘧啶诱发糖尿病小鼠的免疫力的影响。方法通过腹腔注射四氧嘧啶造小鼠糖尿病模型,观察胶原蛋白多肽-铬（Ⅲ）螯合物对小鼠血糖、脾指数、胸腺指数、脾细胞增殖能力、NK细胞杀伤活性、CD40、CD40L的表达等指标的影响。结果胶原蛋白多肽-铬（Ⅲ）螫合物可以有效预防小鼠血糖升高,对脾指数、胸腺指数有一定的恢复作用,脾细胞增殖能力明显增强,NK细胞的杀伤活性被提高,CD40、CD40L的阳性表达率增加。结论胶原蛋白多肽-铬（Ⅲ）能活化免疫细胞,恢复和改善小鼠机体的免疫功能,提高小鼠机体的免疫力,一定程度地减轻四氧嘧啶的毒性作用,降低血糖。     

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)

ABSTRACT: BACKGROUND: No previous studies have compared the DPP-4 inhibitors vildagliptin and sitagliptin in terms of blood glucose levels using continuous glucose monitoring (CGM) and cardiovascular parameters. METHODS: Twenty patients with type 2 diabetes mellitus were randomly allocated to groups who received vildagliptin then sitagliptin, or vice versa. Patients were hospitalized at 1 month after starting each drug, and CGM was used to determine: 1) mean (+/- standard deviation) 24-hour blood glucose level, 2) mean amplitude of glycemic excursions (MAGE), 3) fasting blood glucose level, 4) highest postprandial blood glucose level and time, 5) increase in blood glucose level after each meal, 6) area under the curve (AUC) for blood glucose level [greater than or equal to]180 mg/dL within 3 hours after each meal, and 7) area over the curve (AOC) for daily blood glucose level <70 mg/dL. Plasma glycosylated hemoglobin (HbA1c), glycoalbumin (GA), 1,5-anhydroglucitol (1,5AG), immunoreactive insulin (IRI), C-peptide immunoreactivity (CPR), brain natriuretic peptide (BNP), and plasminogen activator inhibitor-1 (PAI-1) levels, and urinary CPR levels, were measured. RESULTS: The mean 24-hour blood glucose level was significantly lower in patients taking vildagliptin than sitagliptin (142.1 +/- 35.5 vs. 153.2 +/- 37.0 mg/dL; p = 0.012). In patients taking vildagliptin, MAGE was significantly lower (110.5 +/- 33.5 vs. 129.4 +/- 45.1 mg/dL; p = 0.040), the highest blood glucose level after supper was significantly lower (206.1 +/- 40.2 vs. 223.2 +/- 43.5 mg/dL; p = 0.015), the AUC ([greater than or equal to]180 mg/dL) within 3 hours was significantly lower after breakfast (484.3 vs. 897.9 mg/min/dL; p = 0.025), and urinary CPR level was significantly higher (97.0 +/- 41.6 vs. 85.2 +/- 39.9 mug/day; p = 0.008) than in patients taking sitagliptin. There were no significant differences in plasma HbA1c, GA, 1,5AG, IRI, CPR, BNP, or PAI-1 levels between patients taking vildagliptin and sitagliptin. CONCLUSIONS: CGM showed that mean 24-hour blood glucose, MAGE, highest blood glucose level after supper, and hyperglycemia after breakfast were significantly lower in patients with type 2 diabetes mellitus taking vildagliptin than those taking sitagliptin. There were no significant differences in BNP and PAI-1 levels between patients taking vildagliptin and sitagliptin. Trial registration UMIN000007687 KEYWORDS: Vildagliptin; Sitagliptin; Continuous glucose monitoring (CGM); Brain natriuretic peptide (BNP); plasminogen activator inhibitor-1 (PAI-1).     

Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.

A novel bis(6-ethylpicolinato)(H(2)O)oxovanadium(IV) complex (VO(6epa)(2) x (H(2)O)) was prepared and its structure was revealed by X-ray analysis (space group Pc(#7), a=10.838(2), b=11.148(5), c=16.642(3) A, and Z=2). Because VO(6epa)(2) x (H(2)O) exhibited higher in vitro insulinomimetic activity compared to that of vanadyl sulfate in terms of inhibition of free fatty acid (FFA) release from isolated rat adipocytes in the presence of epinephrine, its in vivo effect on whether the complex has a blood glucose normalizing effect was examined in KK-A(y) mice, a model animal of type 2 diabetes mellitus. VO(6epa)(2) x (H(2)O) was found to normalize the high blood glucose levels of KK-A(y) mice when given intraperitoneally at doses of 49 micromol/kg body weight for the first 4 days and then 39 micromol/kg body weight for 10 days. In addition, VO(6epa)(2) x (H(2)O) improved glucose tolerance ability as examined by the oral glucose test and seemed to have little toxicity in terms of serum parameters. VO(6epa)(2) x (H(2)O) showed higher normoglycemic activity than bis(6-methylpicolinato)oxovanadium(IV) (VO(6mpa)(2)) at the same dose. These results indicated that greater enhancement of the blood glucose normalizing effect in KK-A(y) mice by ethyl substitution compared to methyl substitution may be due to its being more strongly lipophilic.     

糖尿病肾脏病与血纤溶酶原激活物抑制剂-1的相互影响

目的：观察糖尿痛肾脏病进展过程中血纤溶酶原激活物抑制剂-1的水平变化及应用药物干预其变化后产生的对糖尿病肾脏病的影响。方法：选择于聊城市人民医院就诊的糖尿病肾脏病患者88例,DKDⅢ期43例,DKDⅣ期45例。分别检测各期患者血PAI-1水平,观察其变化趋势。针对DKDⅢ期患者分为对照组（DKDⅢ-C组）和观察组（DKDⅢ-O组）,对照组给予常规降糖、保护肾脏及血管紧张素转化酶抑制剂等药物治疗。观察组在对照组治疗的基础上给予尿激酶5万U加入100ml生理盐水静脉滴注,每天1次。共14d。比较两组治疗前后血PAI-1水平、24h尿白蛋白量、血肌酐、空腹血糖和凝血酶原时间的变化。结果：DKDⅣ期患者血PAI-1水平明显高于DKDⅢ期患者（P〈0．001）。DKDⅢ-O组患者治疗后血PAI-1水平下降（P〈0．01）,且尿白蛋白减少程度有统计学意义（P〈0．01）,空腹血糖、血肌酐、凝血酶原时间影响无统计学差异（P〉0．05）。DKDⅢ-C组治疗前、后血PAI-1、24h尿白蛋白量、空腹血糖、血肌酐、凝血酶原时间变化均无统计学差异（P〉0．05）。结论：随糖尿病肾脏病进展,血PAI-1水平呈上升趋势,应用药物降低其水平后可减少早期DKD患者尿白蛋白量,对保护肾功能、延缓肾脏病进展有积极意义。     

Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV)

Vanadyl sulfate (VOSO(4)) was given orally to 16 subjects with type 2 diabetes mellitus for 6 weeks at a dose of 25, 50, or 100 mg vanadium (V) daily [Goldfine et al., Metabolism 49 (2000) 1-12]. Elemental V was determined by graphite furnace atomic absorption spectrometry (GFAAS). There was no correlation of V in serum with clinical response, determined by reduction of mean fasting blood glucose or increased insulin sensitivity during euglycemic clamp. To investigate the effect of administering a coordinated V, plasma glucose levels were determined in streptozotocin (STZ)-induced diabetic rats treated with the salt (VOSO(4)) or the coordinated V compound bis(maltolato)oxovandium(IV) (abbreviated as VO(malto)(2)) administered by intraperitoneal (i.p.) injection. There was no relationship of blood V concentration with plasma glucose levels in the animals treated with VOSO(4), similar to our human diabetic patients. However, with VO(malto)(2) treatment, animals with low plasma glucose tended to have high blood V. To determine if V binding to serum proteins could diminish biologically active serum V, binding of both VOSO(4) and VO(malto)(2) to human serum albumin (HSA), human apoTransferrin (apoHTf) and pig immunoglobulin (IgG) was studied with EPR spectroscopy. Both VOSO(4) and VO(malto)(2) bound to HSA and apoHTf forming different V-protein complexes, while neither V compound bound to the IgG. VOSO(4) and VO(malto)(2) showed differences when levels of plasma glucose and blood V in diabetic rodents were compared, and in the formation of V-protein complexes with abundant serum proteins. These data suggest that binding of V compounds to ligands in blood, such as proteins, may affect the available pool of V for biological effects.     

壳寡糖螯合铬对糖尿病小鼠降血糖作用的研究

探讨壳寡糖螯合铬(Cos-Cr)的降血糖作用。选择发育相近的健康雄性小鼠10只为正常对照组,糖尿病小鼠30只随机分为糖尿病对照组、壳寡糖组(Cos)和螯合铬组(Cos-Cr),每组各10只,实验期4 w,测定小鼠血糖值。壳寡糖螯合铬可以降低糖尿病小鼠血糖,增加体重,增加脾脏指数,明显缓解糖尿病小鼠饥饿和烦渴的症状。肝脏损伤明显减轻。同时观察肝组织病理变化。壳寡糖螯合铬对糖尿病小鼠有降糖,改善糖尿病症状的作用。     

Zwitterionic poly(carboxybetaine) hydrogels for glucose biosensors in complex media

Zwitterionic hydrogels based on poly(carboxybetaine) methacrylate (polyCBMA) were developed to protect implantable electrochemical glucose biosensors from biofouling in complex media. To enhance the linearity and sensitivity of the sensing profile, both physical and chemical adsorption methods were developed. Results show that glucose sensors coated with polyCBMA hydrogels via the chemical method achieve very high sensitivity and good linearity in response to glucose in PBS, 10%, 50%, and 100% human blood serum. Essentially identical glucose signals were observed even after prolonged exposure to blood samples for over 12 days. The excellent performance of polyCBMA hydrogel coating offers great promise for designing biocompatible implantable glucose biosensors in biological medium.